NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
Company Details
- Employees
- 40
- Founded
- -
- Address
- South San Francisco, California 94080, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://newlimit.com
- Keywords
- into tech bio? 🧬.
- HQ
- South San Francisco, California
Newlimit Questions
Newlimit's website is https://newlimit.com
Newlimit's LinkedIn profile is https://www.linkedin.com/company/newlimit
Newlimit has
40 employees.
View email and phone details for 40
employees at Newlimit.
Newlimit's industry is
Biotechnology Research
Newlimit's top competitors are
Aditum Bio,
Naderi Engineering, Inc.,
Futurehouse,
Juvena Therapeutics,
Atomwise,
Crystal Bio Solutions, A Member Of Crystal Pharmatech,
Arcadia Science,
Overture Life,
Henlius Usa Inc.,
Synlico Inc..
Newlimit's categories are Biotechnology Research
Newlimit's founding year is 2022
